Articles related to ALOPECIA/HAIR LOSS

Topical Hair Loss Treatment Linked to ED, Anxiety, and Brain Fog, FDA Warns

Topical finasteride absorption through skin into bloodstream produces adverse events consistent with approved oral finasteride products, with 32 documented cases including erectile dysfunction, anxiety, and cognitive symptoms reported between 2019-2024.

Dermatology May 28th 2025

Tags: ADVERSE EVENTS ALOPECIA/HAIR LOSS ANXIETY CORRELATIONS/LINKS DRUG SAFETY & INTERACTIONS ERECTILE DYSFUNCTION (ED) TELEHEALTH

MDLinx

Hair Loss Supplements that Actually Work

Recent evidence indicates that supplements containing hydrolyzed fish-origin collagen, taurine, cysteine, methionine, iron, and selenium can improve the effectiveness of conventional hair loss treatments, offering a valuable adjunct in managing androgenic alopecia and telogen effluvium.

Dermatology July 3rd 2024

Tags: ALOPECIA/HAIR LOSS VITAMINS/SUPPLEMENTS

American Academy of Dermatology

Humbled Again: Alopecic and Aseptic Nodules of the Scalp

A dermatologist describes alopecic and aseptic nodules (AANS) of the scalp, a new clinical entity that has likely escaped many diagnoses. Here is a primer on the condition and how you can ensure a proper diagnosis to alleviate patients’ anxiety, as most have a good prognosis with straightforward therapeutic maneuvers.

Dermatology November 9th 2021

Tags: ALOPECIA/HAIR LOSS SKIN CONDITIONS/RASH

<< 1 2

Trending Topics:

Articles related to ALOPECIA/HAIR LOSS

Topical Hair Loss Treatment Linked to ED, Anxiety, and Brain Fog, FDA Warns

Hair Loss Supplements that Actually Work

Humbled Again: Alopecic and Aseptic Nodules of the Scalp

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form